Tumour
Product introduction
Using RT-qPCR technology to detect the expression of 21 genes in breast cancer (TaqMan probe), including 16 tumor related genes and 5 housekeeping genes. The result is quantified as the recurrence score (Recurrence Score, RS) in order to forecast the 10 years long-term recurrence risk and the benefits of chemotherapy. RS ranges from 0 to 100. The higher the score, the greater the possibility of relapse, and the more it can benefit from chemotherapy. Higher expression of "favorable gene" (hormone related, GSTM1, BAG1) will lead to a lower RS value, while higher expression of "unfavorable gene" (proliferative group, Her-2 group, invasive group and CD68) will result in a higher RS value.
21 gene testing can help you solve the following two problems
Intended for
estrogen receptor positive and 0-3 lymph nodes positive invasive breast cancer patients .
- Individualized Drug Use For Tumor
- Detection Of 21 Gene In Breast Cancer
- 3.Methylated Septin9 Based Colorectal Cancer
- Detection Of Circulating Tumor Cells
- Microsatellite instability (MSI) gene detection
Address: No. 1109, Hsing three road, Ji'nan high tech Zone, Shandong
Phone: 400-966-22200
Web site: www.yinfenggene.com
Mailbox::yinfengyixuejianyan@yfyxjy.com